AVENZO THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 12 Dec 2025)
What this means for you
Not registered yet, but its 19 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97596312
- Mark type
- Stylized text
- Filed
- 19 Sept 2022
- Published for opposition
- 07 Nov 2023
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer
Owner
- Avenzo Therapeutics, Inc., San Diego, CA, US
- Avenzo Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 06 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2025 — SOU EXTENSION 4 GRANTED
- 12 Dec 2025 — SOU EXTENSION 4 FILED
- 12 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2025 — SOU EXTENSION 3 GRANTED
- 24 Jun 2025 — SOU EXTENSION 3 FILED
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2024 — SOU EXTENSION 2 GRANTED
- 17 Dec 2024 — SOU EXTENSION 2 FILED
- 17 Dec 2024 — SOU TEAS EXTENSION RECEIVED